France· FR:69443489
STEROGYL 15 "A" 600 000 UI/1,5 ml, solution buvable en ampoule
A ergocalciferol product containing ergocalciférol, registered in France by DESMA PHARMA, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Ergocalciferol is registered in 7 of 19 countries.
Countries holding a registration under ATC A11CC01 (ergocalciferol), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 5 of them publish a price we can compare per daily dose
Ergocalciferol · ATC A11CC01
7 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ERGOCALCIFÉROL
- Manufacturer
- DESMA PHARMA
- Country
- France (FR)
- ATC code
- A11CC01
- ATC class
- Ergocalciferol
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009309983281 ampoule(s) en verre jaune(brun) de 1,5 mlEUR 1.42
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
68 interactions on record for ergocalciferol.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ergocalciferol · interactions on record
68 records
- 10 severe
- 56 moderate
- 2 minor
Most severe, free to view
- DihydrotachysterolA11CC02severe
- CalcitriolA11CC04severe
- ColecalciferolA11CC05severe
- CalcifediolA11CC06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ergocalciferol in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAacErgo 10,000unit tabletsEssential-Healthcare Ltd
- United StatesErgocalciferolA-S Medication Solutions
- FinlandDevitolOrion Corporation
- BelgiumVitalipid Novum AdultFresenius Kabi
- CzechiaCALCIFEROL BBPBB Pharma a.s., Praha
- NorwaySterogylDB Pharma
- CanadaSANDOZ D-FORTESANDOZ CANADA INCORPORATED
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Calciferol Bbp
- United Kingdom (Northern Ireland) · Ergocalciferol Rph Pharmaceuticals
- Slovakia · Calciferol Bbp
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1a69518-c655-45a1-a4a7-9c51401fcc53 GET /v1/drugs/a1a69518-c655-45a1-a4a7-9c51401fcc53?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69443489",
"date_amm": "1997-03-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ERGOCALCIFÉROL",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ergocalciferol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.